1-6 of 6
Kamal A
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 1425: FBXO11 suppresses epithelial plasticity and proliferation by ubiquitinating the Snail family of transcription factors

Jianrong Lu, Yue Jin, Anitha K. Shenoy, Hao Chen, Huacheng Luo, Lizi Wu, Kamal A. Mohammed
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 1425.
https://doi.org/10.1158/1538-7445.AM2015-1425
Published: 01 August 2015
View article titled, Abstract 1425: FBXO11 suppresses epithelial plasticity and proliferation by ubiquitinating the Snail family of transcription factors
Journal Articles

Abstract 5346: MiR-331-5p targets receptor EphA2 and attenuates tumor growth and migration in NSCLC.

Bhagyalaxmi Sukka-Ganesh, Kamal A. Mohammed, Frederic Kaye, Najmunnisa Nasreen
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 5346.
https://doi.org/10.1158/1538-7445.AM2013-5346
Published: 15 April 2013
View article titled, Abstract 5346: MiR-331-5p targets receptor EphA2 and attenuates tumor growth and migration in NSCLC.
Journal Articles

Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers

Padhma Radhakrishnan, Ulaganathan Baraneedharan, Subhadra Veluchamy, Muthu Dhandapani, Dency D. Pinto, Saravanan Thiyagarajan, Allen Thayakumar, Arun Prasath, Kamal A, Ayyappan Velu, Misti Jain, Nilesh Brijwani, Prasad Narayanan, Vikram D. Kekatpure, Biswanath Majumder, Pradip K. Majumder
Journal: Cancer Research
Cancer Res (2013) 73 (3): 1118–1127.
https://doi.org/10.1158/0008-5472.CAN-12-2545
Published: 31 January 2013
View article titled, Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers
Open the PDF for Inhibition of Rapamycin-Induced AKT Activation Elicits Differential Antitumor Response in Head and Neck Cancers in another window
Journal Articles

Abstract 3073: EphrinA1 inhibits non small cell lung cancer (NSCLC) tumor growth via induction of miRNA-122

BhagyaLaxmi Sukka-Ganesh, Kamal A. Mohammed, Eugene P. Goldberg, Najmunnisa Nasreen
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 3073.
https://doi.org/10.1158/1538-7445.AM2012-3073
Published: 15 April 2012
View article titled, Abstract 3073: EphrinA1 inhibits non small cell lung cancer (NSCLC) tumor growth via induction of <em>miRNA-122</em>
Journal Articles

Abstract 188: EphrinA1 induces microRNA-302b expression in malignant mesothelioma cells and suppresses tumor growth via repression of Mcl-1 gene

Nazli Khodayari, Kamal A. Mohammed, Eugene P. Goldberg, Michael A. Jantz, Najmunnisa Nasreen
Journal: Cancer Research
Cancer Res (2012) 72 (8_Supplement): 188.
https://doi.org/10.1158/1538-7445.AM2012-188
Published: 15 April 2012
View article titled, Abstract 188: EphrinA1 induces microRNA-302b expression in malignant mesothelioma cells and suppresses tumor growth via repression of Mcl-1 gene
Journal Articles

Interleukin 8: An Autocrine Growth Factor for Malignant Mesothelioma

Gabriella Galffy, Kamal A. Mohammed, Patrick A. Dowling, Najmunnisa Nasreen, Melissa J. Ward, Veena B. Antony
Journal: Cancer Research
Cancer Res (1999) 59 (2): 367–371.
Published: 15 January 1999
View article titled, Interleukin 8: <subtitle>An Autocrine Growth Factor for Malignant Mesothelioma</subtitle>
Open the PDF for Interleukin 8: <subtitle>An Autocrine Growth Factor for Malignant Mesothelioma</subtitle> in another window